DEPARTMENT OF HEALTH AND HUMAN SERVICES 
PUBLIC HEALTH SERVICE 
NATIONAL INSTITUTES OF HEALTH 
RECOMBINANT DNA ADVISORY COMMITTEE 
MINUTES OF MEETING 1 
January 14, 1993 
The Recombinant DNA Advisory Committee (RAC) was convened for its fifty-second 
meeting at 9:00 a.m. on January 14, 1993, at the National Institutes of Health, Building 
1, Wilson Hall, 9000 Rockville Pike, Bethesda, Maryland 20892. Dr. LeRoy B. Walters 
(Chair) presided. In accordance with Public Law 92-463, the meeting was open to the 
public. The following were present for all or part of the meeting: 
Committee members: 
Nancy L. Buc, Weil, Gotshal, and Manges 
Alexander Capron, University of Southern California (Conference Phone) 
Ira H. Carmen, University of Illinois 
Gary A. Chase, Johns Hopkins University 
Patricia A. DeLeon, University of Delaware 
E. Peter Geiduschek, University of California, San Diego (Conference Phone) 
Robert Haselkorn, The University of Chicago (Conference Phone) 
Susan S. Hirano, University of Wisconsin 
Donald J. Krogstad, Tulane University School of Public Health 
Brigid G. Leventhal, Johns Hopkins Hospital 
Abbey S. Meyers, National Organization for Rare Disorders 
A. Dusty Miller, Fred Hutchinson Cancer Research Center (Conference Phone) 
Robertson Parkman, Childrens Hospital of Los Angeles 
Leonard E. Post, Parke-Davis Pharmaceutical Division 
Moselio Schaechter, Tufts University School of Medicine (Conference Phone) 
LeRoy B. Walters, Kennedy Institute of Ethics, Georgetown University 
Doris T. Zallen, VA Polytechnic Institute & State University 
Executive secretaiy: 
Nelson A. Wivel, National Institutes of Health 
A committee roster is attached (Attachment). 
1 The RAC is advisory to the National Institutes of Health (NIH), and its 
recommendations should not be considered as final or accepted. The Office of 
Recombinant DNA Activities should be consulted for NIH policy on specific 
issues. 
Recombinant DNA Research, Volume 17 
[5] 
